BridgeMD
New treatment option for Intensive Care (ICU)
Official title Impact of Infusion Line Change Frequency on Infectious Complications Related to Central Venous Catheters in the ICU - A Randomized Controlled Trial
ClinicalTrials.gov ID: NCT07183592
What this study is testing
- What it's testing
- In the intensive care unit, patients' care and secure drugs administration require a central venous catheter. These invasive devices can lead to complications, particularly infections.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult patient
- Any ICU patient with a central venous catheter (inserted by venipuncture) in place for less than 72 hours and with an expected dwell time of at least...
- Patient affiliated with or covered by a social security system
- Patient who has given verbal consent or written consent from a third party or in the event that the patient is unable to give consent.
You likely can't join if
- Patient with a documented bloodstream infection at the time of inclusion
- Patient whose central venous catheter has been in place for more than 72 hours
- Patient with suspected catheter-related infection
- Patient whose study catheter was inserted using a guidewire exchange
- Patient previously enrolled in the study during the same ICU stay
- Patient whose condition, according to the clinician, does not allow safe placement of a central venous catheter, such as:
See the full eligibility criteria
- Adult patient
- Any ICU patient with a central venous catheter (inserted by venipuncture) in place for less than 72 hours and with an expected dwell time of at least 7 days
- Patient affiliated with or covered by a social security system
- Patient who has given verbal consent or written consent from a third party or in the event that the patient is unable to give consent.
- Patient with a documented bloodstream infection at the time of inclusion
- Patient whose central venous catheter has been in place for more than 72 hours
- Patient with suspected catheter-related infection
- Patient whose study catheter was inserted using a guidewire exchange
- Patient previously enrolled in the study during the same ICU stay
- Patient whose condition, according to the clinician, does not allow safe placement of a central venous catheter, such as:
- Allergy to catheter material
- Confirmed deep vein thrombosis at the time of insertion
- Inflammatory skin disorder at the insertion site
- Patient admitted for extensive burns
- Inadequate understanding of the French language
- Pregnant, breastfeeding, or postpartum woman
- Person deprived of liberty by judicial or administrative decision
- Person receiving involuntary psychiatric care
- Person under legal guardianship or other legal protection measure
The study team makes the final eligibility decision.
Where it's taking place
- Saint-Pierre, La Réunion, France
- Albi, France
- Angers, France
- Belfort, France
- Bourges, France
- Caen, France
- Carcassonne, France
- Chartres, France
- Cholet, France
- Colombes, France
- Corbeil-Essonnes, France
- Créteil, France
- Dijon, France
- Garches, France
- Le Mans, France
- Le Puy-en-Velay, France
- Mâcon, France
- Nantes, France
- Orléans, France
- Paris, France
+ 5 more site(s).
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Saint-Pierre, La Réunion, France; Albi, France; Angers, France; Belfort, France; Bourges, France; Caen, France and 19 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.